- Home
- ORKA vs AMAL Comparison
ORKA vs AMAL Comparison
Compare ORKA & AMAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORKA | AMAL |
|---|---|---|
| Founded | 2004 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Commercial Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 966.6M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | ORKA | AMAL |
|---|---|---|
| Price | $30.21 | $32.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $45.22 | $33.50 |
| AVG Volume (30 Days) | ★ 412.0K | 185.6K |
| Earning Date | 11-12-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 1.75% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.32 |
| Revenue | N/A | ★ $306,936,000.00 |
| Revenue This Year | N/A | $10.09 |
| Revenue Next Year | N/A | $8.37 |
| P/E Ratio | ★ N/A | $9.64 |
| Revenue Growth | N/A | ★ 1.29 |
| 52 Week Low | $5.49 | $25.03 |
| 52 Week High | $32.28 | $37.26 |
Technical Indicators
Market Signals| Indicator | ORKA | AMAL |
|---|---|---|
| Relative Strength Index (RSI) | 55.78 | 71.95 |
| Support Level | $29.38 | $31.81 |
| Resistance Level | $32.28 | $32.48 |
| Average True Range (ATR) | 1.63 | 0.76 |
| MACD | -0.11 | 0.20 |
| Stochastic Oscillator | 62.17 | 93.95 |
Price Performance
Historical ComparisonAbout ORKA Oruka Therapeutics Inc.
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management and trust and custody services.